immunoassay development

Ansh Labs is a developer and manufacturer of immunoassay reagent test kits used to advance target discovery, therapeutic development, biomedical research, and clinical diagnostics. The company serves life science researchers, physician researchers, hospitals, commercial laboratories, and public health agencies, and its products support research in reproductive function, pregnancy, central nervous system, atherosclerotic cardiovascular disease, and oncology. Ansh Labs is now part of the VION Biosciences family of companies.

antibody development and screeningassay developmentassay optimizationassay validationCLIAELISAimmunofluorescenceimmunohistochemistryluminogenic microplatemonoclonal antibody developmentneutralizing antibodyWestern blot

BioMEMS Diagnostics was founded in April 2022 to make laboratory-type testing portable. It is developing a diagnostic platform consisting of a single-use test cartridge, a handheld analyzer and a connected app, designed to bring laboratory-type testing to the point of need. The cartridge centers on a patent-pending biosensor chip with twelve wells that can run up to ten different tests from a single sample. The company is privately held, headquartered in Bloomfield Hills, Michigan.

assay developmentbiosensor chip developmentjoint development with partnersmanufacturing

BioVendor is a developer and manufacturer of research and diagnostic products, including immunoassays, recombinant proteins, antibodies, and endotoxin-removal products. Its products are the result of long-term biotechnology R&D activities aimed at the international research and diagnostic community, and its customers include world-renowned scientific institutions.

biotechnology R&Dmonoclonal and polyclonal antibody developmentnext-generation sequencingrecombinant protein production

Enable Biosciences is a team of scientists, engineers, and clinicians creating next-generation tools for predictive medicine. Spun out of UC Berkeley and Stanford in 2016, the company has performed over 150,000 tests and partners with Stanford Healthcare, Harvard Medical School, California Department of Public Health, and JDRF. It develops ultrasensitive antibody detection assays, including ADAP technology, for conditions such as type 1 diabetes, celiac disease, food allergy, Lyme disease, and Zika/dengue.

Antibody Detection by Agglutination-PCR (ADAP)assay development servicesautomated workstationshigh-throughput population screeningmultiplex epitope profiling

Ethos Biosciences develops and manufactures diagnostic reagents, stains, and assay components and kits used across clinical and research laboratories. The company operates from a 127,000-square-foot U.S.-based facility and manufactures IVD products in a GMP-compliant facility with an ISO 13485-certified operation, maintaining FDA product registrations. It supports clinical, research, commercial, and OEM markets with products and services designed for performance, reliability, and ease of use.

ELISA kit development and manufacturingGMP-compliant manufacturingISO 13485-certified operationslateral flow assay development and manufacturingOEM manufacturingprivate label manufacturingquality control testing with authentic specimensreagent manufacturingstain and dye formulation

Green Mountain Antibodies (GMAb) is a US-based laboratory in Vermont that develops and produces custom antibodies for industry, health, and research. It specializes in monoclonal antibodies, hybridoma development, recombinant antibody expression, and polyclonal antibody production, and also sells ready-to-use monoclonal antibodies for hemostasis and immune markers.

antibody conjugationantibody purificationantibody sequencingcell bankingELISA assay developmentFlow CytometryGator analysishybridoma developmentOctet analysispolyclonal antibody productionprotein purificationrecombinant antibody expression